Clinical trials
Myelodysplastic Syndromes trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 38 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affiliated Hospital to Academy of Military Medical Sciences | 3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 3 |
| Nanfang Hospital, Southern Medical University | 3 |
| Peking University People's Hospital | 3 |
| The First Affiliated Hospital of Soochow University | 3 |
| Peking Union Medical College Hospital | 2 |
| Shandong University | 2 |
| iCell Gene Therapeutics | 2 |
| Anhui Provincial Hospital | 1 |
| Biocity Biopharmaceutics Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 38 |
| Leukemia, Myeloid, Acute | 17 |
| Leukemia | 5 |
| Hematologic Neoplasms | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Lymphoma | 2 |
| Myeloproliferative Disorders | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia | 1 |
| Bone Marrow Diseases | 1 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.